Advertisement

Topics

Immediate-release formulation means fewer pills and more flexibility, says Roche

11:30 EDT 3 Jul 2017 | in-PharmaTechnologis

The European Medicines Agency has approved a new tablet formulation of Esbriet (pirfenidone), which Roche says reduces pill-load and increases dosing flexibility for patients with a rare lung disease.

Original Article: Immediate-release formulation means fewer pills and more flexibility, says Roche

NEXT ARTICLE

More From BioPortfolio on "Immediate-release formulation means fewer pills and more flexibility, says Roche"

Advertisement
Quick Search
Advertisement
Advertisement